Article summary
The European Medicines Agency (EMA) has confirmed that it is evaluating an application to use a booster dose of the Comirnaty coronavirus (COVID-19) vaccine in children aged 12–15. The Committee for Medicinal Products for Human Use will be carrying out an accelerated assessment of data submitted by the company that markets the vaccine alongside real life evidence from Israel and EMA will communicate the outcome of the assessment ‘in due course’.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial